Grooms Jamie Mark 4
4 · AxoGen, Inc. · Filed Dec 13, 2017
Insider Transaction Report
Form 4
AxoGen, Inc.AXGN
Grooms Jamie Mark
Director
Transactions
- Sale
Common Stock
2017-12-11$26.35/sh−21,820$574,957→ 257,192 total - Sale
Common Stock
2017-12-12$26.34/sh−16,585$436,849→ 240,607 total
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017 (the "Plan"). All shares pursuant to the Plan have been sold as of the last sales reported herein.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.65. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]These shares of common stock include 108,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $26.90. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]These shares of common stock include 107,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.